On May 7-10, 2024, just a few weeks after the Bundestag passed a Gender Self-Identification Law, the 128th German Medical Assembly passed two memorable resolutions in Mainz:
- “The 128th German Medical Assembly calls on the Federal Government to only permit puberty blockers, sex-change hormone therapies or similar operations on under-18 year olds with gender incongruence (GI) or gender dysphoria (GD) in the context of controlled scientific studies and with the involvement of a multidisciplinary team and a clinical ethics committee and after the completion of medical and, in particular, psychiatric diagnosis and treatment of any mental disorders.
The therapeutic results of any interventions of this kind must be followed up sociologically, medically, child and adolescent psychiatrically, socially and psychologically over a period of at least ten years and the evaluation results must be incorporated into the revision of the ‚Guideline on Gender Incongruence and Gender Dysphoria in Childhood and Adolescence: Diagnosis and Treatment‘.” (Resolution Ic-48) - “The 128th German Medical Assembly calls on the Bundestag to amend the Self-Identification Act to the effect that under eighteen-year-olds may not be permitted to enter or have entered information on their gender and marital status in the personal register without prior specialist child and adolescent psychiatric diagnosis and consultation.” (Resolution Ic-128)
The German Medical Assembly is the annual general meeting of the German Medical Association, to which 250 delegates from the 17 State Chambers of Physicians are sent. Its tasks include the development of nationwide regulations on professional law and positions on health policy. The German Medical Association (Bundesärztekammer) is the central organisation in the system of medical self-administration in Germany.